Abstract Background
Glioblastoma (GBM) is one of the deadliest cancers with no cure. While conventional MRI has been widely adopted for examining GBM clinically, accurate neuroimaging assessment of tumor histopathology for improved diagnosis, surgical planning, and treatment evaluation, remains an unmet need in the clinical management of GBMs.
Methods
We employ a novel Diffusion Histology Imaging (DHI) approach, combining diffusion basis spectrum imaging (DBSI) and machine learning, to detect, differentiate, and quantify areas of high cellularity, tumor necrosis, and tumor infiltration in GBM.
Results
Gd-enhanced T1W or hyper-intense FLAIR failed to reflect the morphological complexity underlying tumor in GBM patients. Contrary to the conventional wisdom that apparent diffusion coefficient (ADC) negatively correlates with increased tumor cellularity, we demonstrate disagreement between ADC and histologically confirmed tumor cellularity in glioblastoma specimens, whereas DBSI-derived restricted isotropic diffusion fraction positively correlated with tumor cellularity in the same specimens. By incorporating DBSI metrics as classifiers for a supervised machine learning algorithm, we accurately predicted high tumor cellularity, tumor necrosis, and tumor infiltration with 87.5%, 89.0% and 93.4% accuracy, respectively.
Conclusion
Our results suggest that DHI might serve as a favorable alternative to current neuroimaging techniques for guiding biopsy or surgery as well as monitoring therapeutic response in the treatment of glioblastoma.
Introduction
Glioblastoma (GBM) is the most common primary malignant brain tumor in adults. 1 It is estimated that 13310 new GBM cases will be diagnosed during 2019 in the U.S. 1 Despite extensive multimodality treatment; including surgical resection, chemotherapy, and radiation; patients with GBM exhibit a dismal 5-year survival rate of 5.5%. 1 Histologically, GBMs are characterized by increased cellularity, vascular proliferation, necrosis, and infiltration into normal brain parenchyma. 2 However, currently, the histopathological complexity of GBM cannot be fully appreciated without microscopic examination of tumor specimens.
Gadolinium (Gd)-enhanced T1-weighted MRI (T1WI) is the standard clinical imaging modality for detection, surgical planning, and evaluation of GBM treatment response. [3] [4] [5] [6] Contrastenhancement in T1W images is clinically interpreted as a measure of tumor burden and is widely used as the target for surgical resection. 6 However, due to the infiltrative nature of GBM, tumor cells are known to extend well beyond the area of contrast enhancement. 3 After treatment, contrast enhancement is not diagnostically specific for GBM since it reflects not only increased Gd leakage due to angiogenesis induced by malignant tumors but also blood-brain barrier disruption triggered by other factors, including radiation effects and ischemia. [7] [8] [9] Therefore, Gd enhancement does not accurately measure tumor burden nor specifically reflect various pathological changes.
Conventional MR sequences such as T2-weighted imaging (T2WI) and fluid-attenuated inversion recovery (FLAIR) imaging have also been employed to localize non-enhancing tumor to complement Gd-enhanced T1WI. The combination of these imaging sequences was adopted into the Response Assessment in Neuro-Oncology (RANO). 3 However, precisely quantifying the increase in T2WI/FLAIR signal intensity remains difficult. Differentiating non-enhancing tumor from other causes of increased T2WI or FLAIR signal intensity, such as edema, radiation effect, ischemic injury, postoperative changes, or other treatment effects, continues to challenge clinicians.
In addition to conventional T1WI and T2WI, diffusion-weighted imaging (DWI) and the derived apparent diffusion coefficient (ADC) have been employed to detect and assess tumor cellularity in many cancers based on the hypothesis that increased tumor cellularity restricts diffusion, leading to decreased ADC values. 10 ADC has been shown to decrease with increasing glioma grade 11 and applied to characterize the infiltrative pattern of recurrent tumor after treatment. 12 However, ADC loses specificity and sensitivity in the presence of co-existing necrosis (increased ADC), tumor infiltration (decreased ADC) and/or vasogenic edema (increased ADC), complicating local brain diffusion characteristics. Combining multiple MR sequences falls short of predicting the complex and heterogeneous GBM tumor microenvironment. Additionally, the gold standard of surgical biopsy carries risk. Thus the development of noninvasive alternatives to decipher the complex GBM tumor histopathology is urgently needed so that clinicians can make rational decisions about continuing, stopping, or changing treatments.
Diffusion basis spectrum imaging (DBSI) utilizes a data-driven multiple-tensor modeling approach to differentiate coexisting morphological features resulting from tumor pathologies or other attributes within an image voxel. We have previously demonstrated that DBSI quantifies tissue injury in an array of central nervous system disorders including multiple sclerosis, 13 cervical spondylotic myelopathy, 14 and epilepsy. 15 In this study, we demonstrate both Gd-enhanced T1WI and hyperintense FLAIR areas contain a spectrum of DBSI-derived morphological signatures in GBM. Using a modified DBSI algorithm to separate inflammation from tumor cellularity, we show DBSI-derived restricted-isotropic-diffusion fraction positively correlated with tumor cellularity in GBM specimens. Finally, to improve the performance of a DBSI-based approach, we developed a more sophisticated and robust Diffusion Histology Imaging (DHI) approach, combining a machine learning algorithm and DBSI metrics, to accurately identify and classify various histopathological components of GBM.
Materials and Methods

Study Design
The study was approved by institutional review board. Informed consent was obtained from all participants. We recruited 16 GBM patients between June 2015 and November 2018 to participate in this study. We applied in vivo Gd-enhanced T1WI, FLAIR, and DBSI on GBM patients (n=3) to obtain multi-metric maps to examine the relative spatial distribution of DBSI metrics among Gd-enhanced, non Gd-enhanced, and hyperintense FLAIR regions. To determine underlying microstructural changes in GBM pathologies, we collected 19 surgically-resected specimens from 13 neurosurgical patients. A more detailed description of experimental procedures including sample preparation, MRI data acquisition, image registration and processing, and data analysis can be found in Supplementary Materials and Methods.
Ex Vivo MRI of Surgical Resection Tumor Specimens
Specimens were formalin-fixed at time of collection and then agarose-gel-embedded before being examined using a 4.7-T Agilent MR scanner (Agilent Technologies, Santa Clara, CA) with a home-made circular surface coil (1.5-cm diameter). A multi-echo spin-echo diffusion-weighted sequence with 99 diffusion-encoding directions with maximum b-values at 3000 s/mm 2 was employed to acquire DW images with a 0.25×0.25 mm 2 in-plane resolution, and 0.5-mm thickness.
Total acquisition time was approximately 4 hours. MR images were zero-filled to 0.125×0.125 mm 2 in-plane resolution for DBSI and DTI analyses.
Cellularity Quantified in H&E and GFAP
We developed a procedure involving down-sampling histological images and co-registering MRI with histological images to enable the voxel-wise correlation between DBSI-restricted diffusion fraction and tumor cellularity. Detailed analysis was performed as described in Supplementary Materials and Methods. Briefly, specimens were sectioned and stained after ex vivo MRI to acquire H&E and GFAP images. High resolution histology images were down-sampled to match DBSI/DTI resolution (125×125 µm 2 ) to enable direct comparison between DBSI/DTI and histological images. Each down-sampled image voxel contained 272×272 original image pixels.
A two-dimensional (2D) thin-plate-spline (TPS) co-registration method was adopted using 50 manually-picked landmarks.
In Vivo MRI of Human Subjects
A 3-T Siemens TIM Trio (Erlanger, Germany) with a 32-channel head coil was used for all in vivo images. MRI data were acquired using a 99-direction diffusion-weighting encoding scheme with maximum b-value of 1500 s/mm 2 at 2×2×2 mm 3 resolution in axial plane covering whole brain.
Acquisition time for DBSI per case was 10 minutes.
Recapitulating Neuropathological Analysis of GBM
The gold standard for detecting tumor is histopathology, reliant on a pathologist's recognition of structural features in tissue specimens and thus requires a surgical procedure with inherent risk. To develop a non-invasive tool that can recapitulate histopathological specificity of tumor induced structural changes, we have developed a novel DHI approach, combining DBSI-derived structural metrics with machine learning, to detect, differentiate, and quantify areas of high tumor cellularity, tumor necrosis, and tumor-infiltrated brain in GBM.
DBSI models brain tumor diffusion-weighted MRI signals as a linear combination of discrete multiple anisotropic diffusion tensors and a spectrum of isotropic diffusion tensors:
Here bk is the k th diffusion gradient; Sk/S0 is the acquired diffusion-weighted signal at direction of bk normalized to non-diffusion-weighted signal; NAniso is number of anisotropic tensors to be determined; φik is the angle between diffusion gradient bk and principal direction of the i th anisotropic tensor; 2 → is b-value of the k th diffusion gradient; λ||i and λ⊥i are axial and radial diffusivity of the i th anisotropic tensor under the assumption of cylindrical symmetry; fi is signalintensity-fraction of the i th anisotropic tensor; a, b are low and high diffusivity limits of isotropic diffusion spectrum; f(D) is signal-intensity-fraction at isotropic diffusivity D.
We preliminarily examined diffusion-weighted MRI signal patterns from different histopathological structures to determine the associated DBSI-metric profiles. Based on the training set of 21 specimen sections, the following isotropic-diffusion profiles were established:
highly-restricted isotropic diffusion, associated with lymphocytes (summation of "#$ at 0≤D≤0.2 µm 2 /ms); restricted-isotropic diffusion, associated with GBM tumor cells (summation of "#$ at 0.2<D≤0.8 µm 2 /ms); and hindered-isotropic diffusion, associated with tumor necrosis (summation of "#$ at 0.8<D≤2 µm 2 /ms). To extend these ex vivo diffusion MRI metric profiles to in vivo human subjects, we employed the following profiles: highly restricted diffusion fraction, summation of "#$ at 0≤D≤0.2 µm 2 /ms; restricted isotropic diffusion, summation of "#$ at 0.2<D≤1.5 µm 2 /ms, and hindered isotropic diffusion, summation of "#$ at 1.5<D≤2.5 µm 2 /ms. The isotropic tensors within this image voxel will remain the same but now anisotropic diffusion tensor will exhibit decreased axial diffusivity and increased radial diffusivity. It is the sensitivity of diffusion-weighted MRI signal to the microstructural changes in the scale up to 10 µm range (depending how one adjusts diffusion-weighting condition) that allows DBSI to more precisely reflect morphological changes resulting from tumor presence or other pathological conditions. By taking the advantage of this feature of DBSI as the input of machine learning algorithms, we created DHI to recapitulate histopathological analysis using MRI.
Statistical Analysis
We used Spearman's rank correlation to measure strengths of monotonically increasing or decreasing associations. Statistically significant results were determined at a predetermined alpha level of 0.05.
To construct a machine learning classifier for histopathological prediction, support vector machine (SVM) with polynomial kernel algorithm was adopted. We performed a linear coregistration between MRI and corresponding neuropathologist-classified H&E images to label each imaging voxel with the gold standard of pathology. Total 21 specimen sections from 19 brain tumor specimens (6605 image voxels) were analyzed to determine DBSI and DTI metrics profiles of each voxel. Imaging voxels from four specimen sections were used for cross-validation testing.
The remaining voxels from other sections were randomly split into training and validation datasets with 1:1 ratio. Total 1000 distinct training-prediction group pairings were run to prevent selection bias. Mean values and 95% confidence intervals were calculated.
Confusion matrices were calculated to illustrate the specific examples of tumor pathologies where predictions were discordant with pathologist-identified pathologies. We evaluated overall accuracy of classifying testing voxels as well as true positive rate, true negative rate and positive predictive value of the model prediction. Receiver operating characteristics (ROC) and precisionrecall (PR) curves were calculated using a one-versus-rest strategy to assess model discrimination for each tumor pathology. Area under curves (AUC) and F1-scores were calculated to compare the relative performance of DHI to pathologist-identified pathologies.
Results
Patient Information
Among the sixteen patients, eleven were male. The mean age at diagnosis was 61.1±14.2 years.
Pathological analysis of tumor specimens confirmed isocitrate dehydrogenase (IDH)-wildtype GBM in all 16 patients (Table S1 ).
DBSI Metrics Are Not Unique to Gd-Enhanced, Non-Enhaned T1W or Hyperintense FLAIR Tumor Regions in Patients
We performed clinical MRI and DBSI on three GBM patients. Representative Gd-enhanced T1W, FLAIR, T2W, DBSI, and ADC images were obtained from a 79-year-old male patient with a right temporal GBM ( Fig. 1A) . We outlined Gd-enhanced and non-enhanced T1W regions to compare the underlying DBSI metrics in these regions, overlaid on MPRAGE-T1W images ( Fig. 1A ).
Based on our DBSI modeling and previous studies, we would predict that DBSI metrics of restricted fraction, hindered fraction, and anisotropic fraction, represent high tumor cellularity, necrosis, and white matter tracts, respectively. Strikingly, DBSI metrics of restricted fraction (red), hindered fraction (blue), and anisotropic fraction (green) were entangled in both Gd-enhancing and non-enhancing regions (Fig. 1A, DBSI) . Specifically, hyperintensity of restricted fraction were widespreaded in Gd non-enhancing region where histology is typically considered to be necrosis, indicating the potential high tumor cellularity in this region that could significantly challenge the current clinical standard.
To determine if specific DBSI structural metrics are enriched in particular clinical MRI sequences, we generated histograms of DBSI-metrics from Gd-enhancing, non-enhancing, and FLAIR hyperintense lesions from all three patients (Fig. 1B) . The common feature among the three GBM cases was the consistent presence of all three DBSI structural metrics in all clinical MRIdefined lesions. Qualitatively, the pattern of DBSI metric distributions did not appear to be unique for Gd-enhancing, non-enhancing, and FLAIR hyperintense regions of GBM tumors, suggesting that these clinical MRI-defined regions harbor mixed pathologies.
Tumor Cellularity Correlated with DBSI-Restricted Fraction, but Not ADC, in Ex Vivo
GBM Specimens
As shown above ( Fig. 1) , in vivo DBSI restricted, hindered, and anisotropic fractions were highly overlapping in MR-lesions of GBM. To definitively determine relationships between DBSI metrics and GBM pathologies, we examined ex vivo DBSI metrics in histologically-identified regions of high tumor cellularity, tumor necrosis, and tumor infiltration in 19 surgically-resected specimens. We performed a thin-plate-spline co-registration on specimens correlating diffusionweighted images with H&E and glial fibrillary acidic protein (GFAP) cellularity maps ( Fig. 2A/B) to allow voxel-to-voxel correlation of histology (H&E and GFAP positive area ratio maps) with ADC, and DBSI-restricted fraction maps (Fig. 2C ). We randomly selected fifty voxels from downsampled H&E images ( Fig. 2A, red squares) and mapped them to the co-registered GFAP, MRImetric maps for voxel-based correlation. Out of twenty specimens, fifteen underwent MRI-H&E and nine underwent MRI-GFAP correlation analyses. The rest were excluded due to unmatched sectioning planes.
Spearman's rank correlation for selected voxels from all specimens (Fig. 2C ) was used to assess the general performance of imaging biomarkers for cellularity in tumor samples. Restricted fraction correlated with H&E (r=0.53, p<0.0001) and GFAP positive areas (r=0.66, p<0.0001). In contrast, ADC failed to correlate with H&E (r=-0.078, p=-0.055) or GFAP (r=0.04, p=0.28).
Qualitative Comparison of DBSI Metrics with GBM Pathologies
To definitively determine relationships between DBSI metrics and GBM pathologies, we examined ex vivo DBSI metrics in histologically-identified regions of high tumor cellularity, tumor necrosis, and tumor infiltration in 19 surgically-resected specimens. A representative tumor specimen (10.1×8.7 mm 2 ) from a 77-year-old female patient demonstrates the relationship between DBSI metrics and tumor pathologies ( Fig. 3) . Hyperintense DWI (i.e. hypointense ADC) defined voxels did not correspond to H&E measures of cellularity ( Fig. 2 and 3A/B ). By coregistering DWI with histological images, representative regions from high tumor cellularity (red square), tumor infiltration (green square), and tumor necrosis (blue square) were selected and enlarged ( Fig. 3B ). High tumor cellularity areas exhibited peaks at highly-restricted and restricted diffusion regions of DBSI-isotropic diffusion spectrum; infiltrated white matter exhibited peaks at the same locations as high cellularity with varying intensities; and tumor necrosis exhibited highlyrestricted and hindered diffusion peaks (Fig. 3C ). The distribution of DBSI restricted, hindered, and anisotropic fraction maps were generated according to empirically-determined thresholds from the analysis of all specimens with matched H&E and DBSI. Although DBSI metrics were overlapping in these pathologies (Fig. 1A/B and 3C) , DBSI restricted and hindered fraction maps qualitatively resembled areas of high tumor cellularity and tumor necrosis, respectively, as identified by a neuropathologist (Fig. 3D ).
Accurate Prediction of Pathological Features in GBM Using Diffusion Histology Imaging
Through image co-registration, MRI voxels corresponding to pathologically-verified areas of high tumor cellularity, tumor necrosis, and tumor infiltration were identified. Image voxel values of DTI ( Fig. 4A ) and DBSI (Fig. 4B ) metrics are presented to demonstrate the distinctions and similarities among these identified tumor pathologies. A multi-parametric examination based on restricted fraction, hindered fraction, and isotropic fraction separated the three pathologically distinct entities ( Fig. 4C ), suggesting analysis based on multiple DBSI metrics could potentially better distinguish among these pathologies rather than single DBSI metrics alone.
We thus developed DHI incorporating a supervised SVM algorithm with modified-DBSI (incorporating a distinction between inflammation and tumors) derived structural metrics as classifiers to construct predictive models to distinguish among different tumor histopathology. We trained and validated the predictive model on image voxels from 17 of the 21 GBM specimen sections. The established model was applied to image voxels from four remaining GBM specimen sections to predict distributions of high tumor cellularity ( Fig. 4D, red) , tumor necrosis ( Fig. 4D , blue) and tumor infiltration ( Fig. 4D, green A comparison between DHI and DTI-SVM was performed using confusion matrices. The DHI (Fig. 4E ) approach demonstrated better prediction accuracy for tumor pathologies compared to DTI-SVM ( Fig. 4F ). We also performed ROC and precision-recall curves analyses for each tumor pathological feature (Fig. 4E, F) . DHI indicated greater ROC and precision-recall AUC values for all the pathological features than DTI-SVM.
Pathological Validation of DHI
From four DHI test specimens, we randomly selected four DWI voxels from each specimen ( Fig.   6A -D) and use corresponding histology as validation. This was achieved by tracking each voxel back to the co-registered down-sampled histological images to compare DHI-predicted pathologies with gold standards. We observed high predictive performance of DHI on individual specimens.
DHI predicted 94.3% of high tumor cellularity areas (Fig. 6A, red) , 97.3% of necrotic areas ( Fig. 6A, blue) and 82.1% of tumor infiltration areas (Fig. 6A, green) in a 77-year-old patient specimen (B122). Indeed, corresponding H&E image tiles (i.e., voxels of down-sampled histology images) verified the randomly-selected DHI predictions of high tumor cellularity ( Fig. 6A: a, b ), tumor infiltration ( Fig. 6A: c) , and tumor necrosis ( Fig. 6A: d) . The second test specimen from a 54-year-old patient (B95) exhibited 98.0% accuracy of DHI predictions of high tumor cellularity voxels (Fig. 6B, red) and 93.3% true prediction rates of tumor necrosis ( Fig. 6B, blue) as validated by corresponding H&E image tiles (high tumor cellularity ( Fig 6B: a, b ) and tumor necrosis ( Fig   6B: c, d) . The third specimen from a 47-year-old female patient (B128) was also assessed, demonstrating that DHI predicted voxels of high tumor cellularity was 99.0% accurate ( Fig. 6C:   a, b, c, d) . In the fourth test specimen from a 57-year-old patient (B94), DHI correctly predicted 100% of tumor infiltration voxels (Fig. 6D ). Corresponding H&E image tiles all indicated tumor infiltration patterns.
Comparing DTI-SVM and DHI Performance on Predicting Tumor Pathologies
We ran 1000 different train-test-split pairings to avoid possible selection bias resulting from the use of specific test subjects. The results were summarized in (Table 1 ).
Discussion
The standard of care for GBM involves surgical resection, followed by radiotherapy with concurrent and adjuvant chemotherapy. Histological assessment of tumor cellularity, necrosis, and infiltration plays a vital role in the clinical decision-making for the management of GBM patients.
The current gold standard of pathological examination following stereotactic biopsy or surgical resection 16 carries potential risks. 17 On some occasions, inconclusive pathological findings may result from inadequate sampling that may necessitate repeat procedures. 18 Thus, noninvasive neuroimaging approaches to facilitate diagnosis or to guide biopsies and surgical planning are needed to improve GBM patient care.
Through voxel-wise comparisons with histological images, we demonstrated that DBSIderived restricted-isotropic-diffusion fraction, hindered-isotropic-diffusion fraction, and anisotropic-diffusion-fraction closely correlate with cellularity, tumor necrosis, and white matter tracts, respectively. However, these metrics alone were not sufficient to clearly distinguish high tumor cellularity, tumor necrosis, or tumor infiltration (Figs. 1, 3 and 4 ). We thus developed DHI, incorporating a SVM predictive model using DBSI metrics as the classifiers, to successfully predict high tumor cellularity, tumor necrosis, and tumor infiltration against the gold standard of histology with high accuracy (Figs. 4-6 ).
Various neuroimaging techniques have been tested to assess the treatment response of brain tumors in clinical practice. Among the wide range of available neuroimaging modalities, contrastenhanced T1WI is currently the method of choice for brain tumor diagnosis. Unfortunately, Gdenhanced T1WI lacks specificity because it merely reflects a disrupted blood-brain barrier. 19 Chemotherapy, radiation, and newer clinical trial treatments such as immunotherapies produce [18F]-fluoroethyl)-L-tyrosine (FET), 26 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine (FDOPA), 27 also provide complementary diagnostic information in GBM detection. In addition, stimulated Raman scattering microscopy, 28 optical coherence tomography, 29 and mass spectroscopy 30 have also been developed to improve glioma diagnosis. However, most of these techniques do not have the capability of quantifying individual pathological components in a noninvasive manner.
To address limitations of conventional MRI, diffusion-weighted MRI-derived ADC has been one of the most widely researched tools for the evaluation of tumor cellularity and grade. 10 Although increased tumor cellularity has been associated with decreased ADC, the expression of aquaporin in high-grade glioma, 31 vasogenic edema, 32 and necrosis 33 may obviate the interpretation of expected diffusion restriction caused by high cellularity. Indeed, in our tested tumor specimens, ADC did not correlate with cellularity while the DBSI-derived restricted fraction significantly correlated with both H&E-and GFAP staining-based cellularity measures (Fig. 2) .
One observation in the present study contradicting the widely-accepted role of ADC in tumor cellularity is the significantly restricted diffusion observed in white matter tracts ( Fig. 3) , where the disrupted fiber network greatly increased diffusion restriction. Thus, our results further support that ADC alone cannot be considered a reliable tumor biomarker. DBSI isotropic-ADC showed the expected negative correlation with H&E-cellularity (r=-0.16, p=0.00004) but did not correlate with GFAP-cellularity (r=0.07, p=0.13). DBSI-restricted fraction displayed statistically significantly high correlation with H&E-and GFAP-cellularity (r=0.53, 0.66, respectively; p<0.0001).
Fig. 3. Association between DBSI-metrics and neuropathologist-identified tumor pathology.
A surgically-resected specimen from a 77-year-old female GBM patient was analyzed via T2WI High tumor cellularity signal (red) exhibits peaks at highly-restricted and restricted diffusion regions; infiltrated white matter signal (green) exhibits peaks at the same locations as high cellularity with varying intensities; and tumor necrosis signal (blue) exhibits highly-restricted and hindered diffusion regions (C). Based on these distributions, we generated DBSI highly-restricted, restricted, and hindered isotropic-diffusion signal fraction maps (D). These maps reveal that highly-restricted fraction is high in tumor infiltration and high tumor cellularity regions; restricted fraction is highly associated with high tumor cellularity regions (consistent with findings of figure   2 ); and hindered diffusion fraction is highly correlated with H&E tumor necrosis regions. The intensity gradient on restricted fraction map reflects tumor cellularity change. anisotropic fractions reveal that the three tumor pathologies can be resolved by combining the three DBSI metrics (C). Representative histology images corresponding to selected DBSI image voxels were presented. For this independent dataset (n=1963), DHI predicted voxels showed great match with histology, affording a 96.2% overall accuracy in predicting high tumor cellularity, tumor necrosis and tumor infiltration (D). Confusion matrices reveal DHI (E) is more accurate than DTI-SVM (F) in predicting high tumor cellularity, tumor necrosis and tumor infiltration.
Additionally, DHI showed greater AUC values than DTI-SVM on both ROC and precision-recall curves. 
